Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Ajanta Pharma Limited ( (IN:AJANTPHARM) ) has provided an update.
Ajanta Pharma Limited has announced that its Board of Directors will meet on November 3, 2025, to consider the declaration of the first interim dividend for the financial year ending March 31, 2026. Additionally, the company has set November 10, 2025, as the record date for the payment of the interim dividend, if declared. This decision is part of the company’s regular financial proceedings and could impact shareholder returns and market perception.
More about Ajanta Pharma Limited
Ajanta Pharma Limited is a pharmaceutical company based in Mumbai, India. It specializes in the development, manufacturing, and marketing of pharmaceutical products, focusing on therapeutic segments such as cardiology, dermatology, ophthalmology, and pain management.
Average Trading Volume: 3,187
Technical Sentiment Signal: Sell
Current Market Cap: 306.6B INR
For a thorough assessment of AJANTPHARM stock, go to TipRanks’ Stock Analysis page.